JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.50, sa.10, ss.1977-1984, 2024 (SCI-Expanded)
Aim: To assess the efficacy of intratesticular injection of autologous platelet-richplasma (PRP) in men with non-obstructive azoospermia (NOA) and a history offailed microdissection-testicular sperm extraction (mTESE) procedures. Methods: A prospective case series of a cohort study was conducted involving couples diagnosed with NOA. Patients with at least one failed mTESE procedure were included. Intratesticular PRP injection was performed using a standardized protocol. Follow-up assessments included sperm analysis, hormonal evaluation, and in vitro fertilization (IVF) outcomes. Results: Data from 177 men with NOA were analyzed, with 135 patients meeting eligibility criteria. PRP treatment resulted in positive sperm retrieval rates of27.5% in patients with one prior failed mTESE procedure and 16.4% in patients with two or more failed attempts. IVF outcomes showed fertilization rates of86.4% and 100.0% in respective groups, with pregnancy rates of 36.8% and 22.2%per embryo transfer. Histopathological examination post-mTESE revealed varied patterns, including Sertoli cell-only syndrome and maturation arrest. Conclusions: Intratesticular PRP injection shows promise as a potential therapeutic approach for NOA patients with prior failed mTESE procedures, demonstrating improved sperm retrieval rates and favorable IVF outcomes. Further randomized controlled trials are warranted to validate these findings and refinethe technique's efficacy in male infertility management to answer the question ofwhether PRP could significantly improve the second attempt retrieval rate